SPNE - SeaSpine Holdings Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
12.90
-0.06 (-0.48%)
As of 12:13PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close12.96
Open12.99
Bid12.89 x 800
Ask12.98 x 1800
Day's Range12.46 - 12.99
52 Week Range10.44 - 20.75
Volume17,647
Avg. Volume56,086
Market Cap246.308M
Beta (3Y Monthly)0.14
PE Ratio (TTM)N/A
EPS (TTM)-2.15
Earnings DateOct 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.00
  • GlobeNewswire

    SeaSpine to Present at the 31st Annual Piper Jaffray Healthcare Conference

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming Piper Jaffray Healthcare Conference in New York. SeaSpine is scheduled to present on Wednesday, December 4, 2019 at 4:00pm ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company’s website at www.seaspine.com.

  • Thomson Reuters StreetEvents

    Edited Transcript of SPNE earnings conference call or presentation 29-Oct-19 8:30pm GMT

    Q3 2019 SeaSpine Holdings Corp Earnings Call

  • SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates
    Zacks

    SeaSpine Holdings (SPNE) Reports Q3 Loss, Tops Revenue Estimates

    SeaSpine (SPNE) delivered earnings and revenue surprises of -27.50% and 3.66%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    SeaSpine Reports Record Revenue, Driven by 16% U.S. Spinal Implants Growth

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the third quarter ended September 30, 2019. Keith C. Valentine, President and Chief Executive Officer, said, “The Mariner revision and MIS systems are key new products in our spinal implants portfolio that allow us to attract the high-quality distribution that we believe, coupled with our other initiatives, will generate consistent U.S. spinal implants revenue growth in the mid-teens through 2020, with further acceleration anticipated in 2021.

  • GlobeNewswire

    SeaSpine to Report Third Quarter 2019 Financial Results on October 29, 2019

    CARLSBAD, Calif., Oct. 16, 2019 -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal.

  • GlobeNewswire

    SeaSpine® Announces Exclusive Development and Licensing Agreement with restor3D®

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has entered into an exclusive (field-based) development and licensing agreement with restor3d, Inc., a privately-held medical device company co-founded by Ken Gall, Professor of Mechanical Engineering at Duke University, that specializes in developing 3D-printed implants with enhanced anatomical fit and superior integrative properties.  Financial terms were not disclosed. This partnership provides SeaSpine entry into, and an opportunity to differentiate within, the 3D-printed interbody space, one of the fastest growing segments in spine.  restor3d’s materials science technology complements SeaSpine's broad and differentiated orthobiologics portfolio with the goal of driving both clinical and economic advantages.  The parties plan to develop 3D-printed interbody devices that are designed specifically for a wide range of surgical approaches.  SeaSpine expects to commercialize its first 3D-printed interbody devices to be developed under this agreement in the second half of 2020.

  • GlobeNewswire

    SeaSpine to Present at the Cantor Global Healthcare Conference

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming Cantor Global Healthcare Conference in New York. SeaSpine is scheduled to present on Thursday, October 3, 2019 at 1:50pm ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company’s website at www.seaspine.com.

  • What Percentage Of SeaSpine Holdings Corporation (NASDAQ:SPNE) Shares Do Insiders Own?
    Simply Wall St.

    What Percentage Of SeaSpine Holdings Corporation (NASDAQ:SPNE) Shares Do Insiders Own?

    A look at the shareholders of SeaSpine Holdings Corporation (NASDAQ:SPNE) can tell us which group is most powerful...

  • GlobeNewswire

    SeaSpine to Host Analyst & Investor Event on September 26, 2019

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will host an Analyst & Investor Event in Chicago, Illinois on Thursday, September 26 from 7:30 a.m. to 9:00 a.m. Central Time. The meeting will include remarks from members of the SeaSpine leadership team on the Company’s differentiated technologies and growth strategy. A live webcast, including slide presentation, will be available on the SeaSpine website at www.investor.seaspine.com.

  • GlobeNewswire

    SeaSpine to Present at the Ladenburg Thalmann 2019 Healthcare Conference

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming 2019 Ladenburg Thalmann Healthcare Conference in New York. SeaSpine is scheduled to present on Tuesday, September 24, 2019 at 1:00pm ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company’s website at www.seaspine.com.

  • Thomson Reuters StreetEvents

    Edited Transcript of SPNE earnings conference call or presentation 1-Aug-19 8:30pm GMT

    Q2 2019 SeaSpine Holdings Corp Earnings Call

  • GlobeNewswire

    SeaSpine to Present at the 14th Annual Wells Fargo Healthcare Conference

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in the upcoming 14th Annual Wells Fargo Healthcare Conference in Boston. SeaSpine is scheduled to present on Thursday, September 5, 2019 at 1:20pm ET. A live webcast of the presentation will be available online from the Investor Relations page of the Company’s website at www.seaspine.com.

  • GlobeNewswire

    SeaSpine Announces Launch of Mariner® MIS Posterior Fixation System

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of initial surgeries of the Mariner® MIS Posterior Fixation System. Mariner MIS is a comprehensive, minimally invasive posterior fixation system built upon the Mariner platform to simplify the treatment of a wide range of spinal pathologies.  Minimally invasive procedures are typically associated with reduced blood loss, incision size, and hospital stay compared to traditional open procedures.   These advantages are expected to drive a continued shift towards minimally invasive surgery (MIS) adoption and associated growth of the MIS spinal implant market.

  • SeaSpine Holdings (SPNE) Q2 2019 Earnings Call Transcript
    Motley Fool

    SeaSpine Holdings (SPNE) Q2 2019 Earnings Call Transcript

    SPNE earnings call for the period ending June 30, 2019.

  • SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates
    Zacks

    SeaSpine Holdings (SPNE) Reports Q2 Loss, Tops Revenue Estimates

    SeaSpine (SPNE) delivered earnings and revenue surprises of 7.32% and 0.92%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    SeaSpine Reports Second Quarter 2019 Financial Results

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended June 30, 2019 and updated its financial outlook for 2019.

  • GlobeNewswire

    SeaSpine Announces the Launch of the Shoreline RT™ Cervical Interbody Implant System, featuring Reef Topography™

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of the first surgery for its Shoreline RT Cervical Interbody Implant System. Shoreline RT represents the first in a series of products that will marry the Company’s proprietary NanoMetalene® technology with Reef Topography. The Company anticipates launching five additional products with NanoMetalene technology and Reef Topography by the end of 2020.

  • GlobeNewswire

    SeaSpine Announces Launch of Mariner® Outrigger® Revision System

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the limited commercial launch of the Mariner Outrigger Revision System. Mariner Outrigger is an implant system providing surgeons a high level of versatility for multiple revision applications. As an adjunct to the Mariner Posterior Fixation system, Mariner Outrigger includes a variety of options to effectively revise and extend previous fusions.

  • GlobeNewswire

    SeaSpine Announces 20,000th NanoMetalene® Implantation

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 20,000th NanoMetalene® interbody device. This milestone exemplifies SeaSpine's mission to develop clinically relevant, cost-effective procedural solutions to treat spinal disorders by providing high-quality, differentiated, and complementary technologies that leverage the Company’s core competencies in orthobiologics, interbody devices, and modular spinal implant systems. NanoMetalene is a proprietary surface technology for interbody implants that incorporates a sub-micron layer of commercially pure titanium molecularly bonded to a PEEK implant using a high-energy, low-temperature process referred to as atomic fusion deposition.

  • SeaSpine Holdings (SPNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks

    SeaSpine Holdings (SPNE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Did SeaSpine Holdings Corporation (NASDAQ:SPNE) Insiders Sell Shares?
    Simply Wall St.

    Did SeaSpine Holdings Corporation (NASDAQ:SPNE) Insiders Sell Shares?

    We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...

  • Will SeaSpine Holdings (SPNE) Report Negative Q2 Earnings? What You Should Know
    Zacks

    Will SeaSpine Holdings (SPNE) Report Negative Q2 Earnings? What You Should Know

    SeaSpine (SPNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire

    SeaSpine to Report Second Quarter 2019 Financial Results on August 1, 2019

    CARLSBAD, Calif., July 19, 2019 -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal.

  • GlobeNewswire

    SeaSpine Announces Portfolio Expansion of OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the product release of its OsteoStrand™ and OsteoStrand™ Plus Demineralized Bone Fibers with its new integrated, hydration syringe system.  The new packaging allows the surgeon to seamlessly hydrate the DBM Fibers with blood, saline, or bone marrow aspirate (BMA) in a convenient, open-bore syringe system. The first OsteoStrand Plus implantations were completed by Dr. Erik Olsson at Southern Oregon Spine Care and Dr. Warren Yu at Precision Orthopedics in Maryland.

  • GlobeNewswire

    SeaSpine Announces Full Commercial Launch of Regatta® Lateral System

    SeaSpine Holdings Corporation (SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Regatta® Lateral System, featuring NanoMetalene® technology. “The Regatta Lateral System is the culmination of the extensive lateral expertise of our product development and marketing teams and the valuable surgeon input gained through a comprehensive alpha evaluation,” stated Dennis Cirino, Senior Vice President, Global Spinal Systems.